UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunology and efficacy of MF59-adjuvanted vaccines

Human vaccines & immunotherapeutics, 2018-12, Vol.14 (12), p.3041-3045

2018

Volltextzugriff (PDF)

Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses

Nature communications, 2018-01, Vol.9 (1), p.359-12, Article 359

2018

Volltextzugriff (PDF)

SARS‐CoV‐2 Spike Stem Protein Nanoparticles Elicited Broad ADCC and Robust Neutralization against Variants in Mice

Small (Weinheim an der Bergstrasse, Germany), 2022-06, Vol.18 (25), p.e2200836-n/a

2022

Volltextzugriff (PDF)

Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle

PLoS pathogens, 2022-08, Vol.18 (8), p.e1010755-e1010755

2022

Volltextzugriff (PDF)

Universal influenza vaccines: from viruses to nanoparticles

Expert review of vaccines, 2018-11, Vol.17 (11), p.967-976

2018

Volltextzugriff (PDF)

Influenza immune imprinting synergizes PEI-HA/CpG nanoparticle vaccine protection against heterosubtypic infection in mice

Vaccine, 2024-01, Vol.42 (2), p.111-119

2024

Volltextzugriff (PDF)

Layered protein nanoparticles containing influenza B HA stalk induced sustained cross-protection against viruses spanning both viral lineages

Biomaterials, 2022-08, Vol.287, p.121664-121664, Article 121664

2022

Volltextzugriff (PDF)

Effective adjuvantation of nanograms of influenza vaccine and induction of cross-protective immunity by physical radiofrequency adjuvant

Scientific reports, 2022-12, Vol.12 (1), p.21249-21249, Article 21249

2022

Volltextzugriff (PDF)

Physical radiofrequency adjuvant enhances immune responses to influenza H5N1 vaccination

The FASEB journal, 2022-03, Vol.36 (3), p.e22182-n/a

2022

Volltextzugriff (PDF)

Double‐Layered M2e‐NA Protein Nanoparticle Immunization Induces Broad Cross‐Protection against Different Influenza Viruses in Mice

Advanced healthcare materials, 2020-01, Vol.9 (2), p.e1901176-n/a

2020

Volltextzugriff (PDF)

Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses

PloS one, 2018-01, Vol.13 (1), p.e0190868-e0190868

2018

Volltextzugriff (PDF)

Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus

Molecular therapy, 2013-02, Vol.21 (2), p.485-492

2013

Volltextzugriff (PDF)

Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs

PloS one, 2019-06, Vol.14 (6), p.e0216871-e0216871

2019

Volltextzugriff (PDF)

Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection

Scientific reports, 2017-12, Vol.7 (1), p.17360-12, Article 17360

2017

Volltextzugriff (PDF)

Monophosphoryl lipid A-adjuvanted nucleoprotein-neuraminidase nanoparticles improve immune protection against divergent influenza viruses

Nanomedicine, 2023-01, Vol.47, p.102614-102614, Article 102614

2023

Volltextzugriff (PDF)

Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus

Journal of Virology, 2007-04, Vol.81 (7), p.3514-3524

2007

Volltextzugriff (PDF)

Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin

Scientific reports, 2021-02, Vol.11 (1), p.4151-4151, Article 4151

2021

Volltextzugriff (PDF)

Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus

Proceedings of the National Academy of Sciences - PNAS, 2011-01, Vol.108 (2), p.757-761

2011

Volltextzugriff (PDF)

Adjuvant effects of combination monophosphoryl lipid A and poly I:C on antigen-specific immune responses and protective efficacy of influenza vaccines

Scientific reports, 2023-07, Vol.13 (1), p.12231-12231, Article 12231

2023

Volltextzugriff (PDF)

Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles

International journal of molecular sciences, 2023-06, Vol.24 (13), p.10612

2023

Volltextzugriff (PDF)

Built‐in RNA‐mediated chaperone (chaperna) for antigen folding tailored to immunized hosts

Biotechnology and bioengineering, 2020-07, Vol.117 (7), p.1990-2007

2020

Volltextzugriff (PDF)

MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine

Antiviral research, 2018-08, Vol.156, p.107-115

2018

Volltextzugriff (PDF)

Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity

PloS one, 2013-10, Vol.8 (10), p.e75368-e75368

2013

Volltextzugriff (PDF)

Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine

The Journal of immunology (1950), 2017-01, Vol.198 (1), p.279-291

2017

Volltextzugriff (PDF)

Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity

Biotechnology and bioengineering, 2015-06, Vol.112 (6), p.1102-1110

2015

Volltextzugriff (PDF)

1 – 25 von 1.331

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.193)
Mit Volltextzugriff
(1.121)

Publikationsform

Sprache

Englisch
(1.164)
Koreanisch
(161)
Japanisch
(2)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(817)
Life Sciences & Biomedicine
(656)
Humans
(387)
Female
(284)
Animals
(281)
Male
(219)
Mice
(182)
Middle Aged
(178)
Aged
(152)
Vaccines
(112)
Mice, Inbred Balb C
(106)
Biological And Medical Sciences
(104)
Influenza
(100)
Science & Technology - Other Topics
(98)
Immunology
(97)
Viruses
(86)
Influenza Vaccines - Immunology
(84)
Neurosciences & Neurology
(84)
Virology
(83)
Adult
(81)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(56)
Stroke
(41)
Scientific Reports
(27)
Virology
(27)
Journal Of Virology
(26)
The Journal Of Immunology
(23)
Journal Of Korean Medical Science
(22)
Vaccine
(22)
Nuclear Medicine And Molecular Imaging
(21)
Vaccines
(15)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Immunology and efficacy of MF59-adjuvanted vaccines

Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses

SARS‐CoV‐2 Spike Stem Protein Nanoparticles Elicited Broad ADCC and Robust Neutralization against Variants in Mice

Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle

Universal influenza vaccines: from viruses to nanoparticles

Influenza immune imprinting synergizes PEI-HA/CpG nanoparticle vaccine protection against heterosubtypic infection in mice

Layered protein nanoparticles containing influenza B HA stalk induced sustained cross-protection against viruses spanning both viral lineages

Effective adjuvantation of nanograms of influenza vaccine and induction of cross-protective immunity by physical radiofrequency adjuvant

Physical radiofrequency adjuvant enhances immune responses to influenza H5N1 vaccination

Double‐Layered M2e‐NA Protein Nanoparticle Immunization Induces Broad Cross‐Protection against Different Influenza Viruses in Mice

Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses

Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus

Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs

Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection

Monophosphoryl lipid A-adjuvanted nucleoprotein-neuraminidase nanoparticles improve immune protection against divergent influenza viruses

Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus

Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin

Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus

Adjuvant effects of combination monophosphoryl lipid A and poly I:C on antigen-specific immune responses and protective efficacy of influenza vaccines

Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles

Built‐in RNA‐mediated chaperone (chaperna) for antigen folding tailored to immunized hosts

MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine

Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity

Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine

Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity

Suchergebnisse filtern